Novo Nordisk’s Bold Restructuring: Job Cuts and Strategic Shift

Novo Nordisk axes 9,000 jobs and slashes guidance as GLP-1 drugs face competition. Can the new CEO turn the tide...

10/09/2025

2 views

Novo Nordisk’s CEO Shift to Lead Weight Loss Market

Novo Nordisk shakes up leadership to reclaim the weight loss drug throne from Eli Lilly. Can a new CEO turn...

19/05/2025

0 views

Eli Lilly’s obesity drug Zepbound faces a CVS-Wegovy deal. Will it shake their market lead? Dive into the drama...

07/05/2025

0 views

Eli Lilly's new weight loss pill shows promise in trials, but can it dominate the market? Dive into the results...

17/04/2025

0 views